September 8, 2025

BioNTech SE (BNTX) Stock Analysis: Exploring Growth Potential with a 21% Upside

BioNTech SE (NASDAQ: BNTX), a leading biotechnology company headquartered in Mainz, Germany, has been a focal point for investors interested in the healthcare sector, particularly in..

Encompass Health Corporation (EHC) Investor Outlook: Strong Buy Ratings Signal Potential Upside

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector, particularly within the medical care facilities industry, with a robust market capitalization of $12.65 billion...

Koninklijke Philips N.V. (PHG) Stock Analysis: Unlocking a 17.32% Potential Upside in Healthcare Innovation

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector, is drawing attention from investors as it embarks on a transformative journey within the medical..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 27% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH), a prominent player in the healthcare sector, is capturing investor interest with its current valuation and potential upside. With a..

Bio-Techne Corp (TECH): Investor Outlook Reveals 21.73% Potential Upside in Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH) presents a compelling opportunity for investors seeking to navigate the dynamic landscape of the biotechnology sector. With a market capitalization of $8.46..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 10.43% Potential Upside for Investors

Genmab A/S (NASDAQ: GMAB), a leading Danish biotechnology firm, is capturing the attention of investors with a robust pipeline of antibody-based products aimed at treating cancer..

Gilead Sciences, Inc. (GILD) Stock Analysis: A Look at Its 8.23% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. With a substantial market cap of..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Exploring a 7.74% Upside Potential Amidst Impressive Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has been capturing attention in the biotechnology sector with its robust focus on developing novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH)...

Globus Medical, Inc. (GMED) Stock Analysis: Riding the Wave of a 36% Potential Upside

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, specifically within the medical devices industry, is garnering significant attention from investors. With a..

Illumina, Inc. (ILMN) Stock Analysis: Evaluating the 13.16% Potential Upside for Strategic Investors

Illumina, Inc. (NASDAQ: ILMN), a pioneer in the healthcare sector, specifically within the diagnostics and research industry, has been a stalwart in genetic and genomic analysis..

Repligen Corporation (RGEN) Stock Analysis: A 44% Upside Potential Beckons Investors

Repligen Corporation (NASDAQ: RGEN) is generating considerable buzz among investors, thanks to an impressive potential upside of 44.33%, as highlighted by its current market dynamics. Operating..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 51.56% Potential Upside

Investors seeking opportunities in the healthcare sector might want to turn their attention to Bruker Corporation (NASDAQ: BRKR), a leading player in the medical devices industry...

ResMed Inc. (RMD) Stock Analysis: Exploring a 5.34% Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a leader in the healthcare sector, particularly in medical instruments and supplies, presents an intriguing opportunity for investors. With a market capitalization..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Healthcare Technology Frontier with Robust Revenue Growth

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector, with a strong market capitalization of $13.83 billion and a current stock price..

Labcorp Holdings Inc. (LH) Stock Analysis: Strong Buy Ratings Propel Investor Outlook

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, particularly in the Diagnostics & Research industry, has captured investor interest with its robust..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 25.74% Potential Upside Amidst Robust Revenue Growth

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, is capturing investor attention with its significant growth potential and innovative therapeutic solutions. Based..

Tenet Healthcare Corporation (THC) Stock Analysis: Investor Optimism with High EPS and Robust Growth Potential

For investors seeking exposure in the healthcare sector, Tenet Healthcare Corporation (NYSE: THC) presents an intriguing opportunity. With its roots firmly planted in the medical care..

STERIS plc (STE): Investor Outlook Reveals 11% Upside Potential for Healthcare Innovator

STERIS plc (NYSE: STE), a stalwart in the healthcare sector, continues to capture investor attention with its robust market performance and promising growth trajectory. With a..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 60.73% Potential Upside in the Diagnostic and Therapeutic Market

Lantheus Holdings, Inc. (NASDAQ: LNTH) has caught the attention of investors with its robust portfolio of diagnostic and therapeutic products. As a key player in the..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A High Potential Play in Precision Oncology with 82.87% Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing the attention of investors with its innovative approach in the biotechnology sector, particularly within the field of precision oncology...

Search

Funds

September 8, 2025

Search

Funds

September 8, 2025

FTSE 100

Funds